CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Dyadic International, Inc. - DYAI CFD

1.4969
2.05%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0362
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.4669
Open 1.4669
1-Year Change -2.54%
Day's Range 1.4469 - 1.5069
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 16, 2025 1.4669 0.0100 0.69% 1.4569 1.6669 1.4569
Jan 15, 2025 1.5469 0.0100 0.65% 1.5369 1.6369 1.4369
Jan 14, 2025 1.5469 -0.0800 -4.92% 1.6269 1.6569 1.5169
Jan 13, 2025 1.6169 0.0500 3.19% 1.5669 1.6469 1.5669
Jan 10, 2025 1.6369 0.0100 0.61% 1.6269 1.6769 1.4969
Jan 8, 2025 1.7169 -0.1800 -9.49% 1.8969 1.9069 1.6769
Jan 7, 2025 1.9369 0.0700 3.75% 1.8669 2.0569 1.7969
Jan 6, 2025 1.9069 0.0600 3.25% 1.8469 1.9669 1.7669
Jan 3, 2025 1.8269 0.0700 3.98% 1.7569 1.8269 1.6269
Jan 2, 2025 1.7269 -0.0400 -2.26% 1.7669 1.7969 1.6969
Dec 31, 2024 1.7269 0.0200 1.17% 1.7069 1.7669 1.5669
Dec 30, 2024 1.7569 -0.2400 -12.02% 1.9969 1.9969 1.7169
Dec 27, 2024 1.9269 0.1700 9.68% 1.7569 2.0269 1.7169
Dec 26, 2024 1.7269 -0.0200 -1.14% 1.7469 1.8369 1.6469
Dec 24, 2024 1.6969 -0.0900 -5.04% 1.7869 1.8269 1.5869
Dec 23, 2024 1.7469 -0.0100 -0.57% 1.7569 1.8969 1.7469
Dec 20, 2024 1.7169 -0.1500 -8.03% 1.8669 2.0069 1.7169
Dec 19, 2024 1.8769 -0.0900 -4.58% 1.9669 2.0469 1.6069
Dec 18, 2024 1.9769 0.5600 39.52% 1.4169 2.1769 1.3469
Dec 17, 2024 1.4069 -0.0200 -1.40% 1.4269 1.4669 1.3569

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Dyadic International, Inc. Company profile

About Dyadic International, Inc.

Dyadic International, Inc. is a biotechnology platform company. The Company is focused on developing C1 platform for use in human and animal pharmaceutical applications across the world. The C1 platform technology is based on the Myceliopthora thermophila fungus, which the Company named it as C1. The C1 gene expression platform is used in the discovery, development and manufacturing of biologic medicines and vaccines. The C1 technology is a fungal expression system for gene discovery, development, and production of enzymes and other proteins. The C1 technology is commercially available solutions to uptake genes and develop industrial processes to produce volumes of enzymes and other protein products. The Company is also working on COVID-19 related vaccine and antibody opportunities, including COVID-19 vaccine candidate, DYAI-100.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Dyadic International, Inc. revenues increased 66% to $2.1M. Net loss increased 20% to $8.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development - Balancing val increase from $2M to $5.8M (expense), General and administration increase of 61% to $3.8M (expense).

Equity composition

Common Stock $.001 Par, 12/10, 100M auth., 31,138,120 issd. insiders own 6.80%.10/29/04, acquired CCP Worldwide Inc. as a reverse acquisition.01/08, Company delisted from AMEX to OTC Pink Sheets.

Industry: Biotechnology & Medical Research (NEC)

1044 North U.S. Highway One
Suite 201
JUPITER
FLORIDA 33477
US

People also watch

BTC/USD

104,515.35 Price
+4.320% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

ETH/USD

3,475.00 Price
+4.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

3.29 Price
-0.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01639

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading